Adenoid Cystic Carcinoma is a type of cancer that commonly affects the salivary glands. The ICD-10 code for Adenoid Cystic Carcinoma is C08.1. In the previous ICD-9 coding system, the corresponding code was 142.2. Adenoid Cystic Carcinoma is a rare malignancy, characterized by slow growth and a tendency to invade nerves and blood vessels. Early diagnosis and treatment are crucial for better outcomes.
Adenoid cystic carcinoma (ACC) is a rare form of cancer that typically arises in the salivary glands but can also affect other areas such as the breast, respiratory tract, or lacrimal glands. In the International Classification of Diseases, 10th Revision (ICD-10), the specific code for ACC is C08.1 for major salivary glands, while C08.9 is used for unspecified sites of the salivary glands. The ICD-9 code for ACC is 142.2, which denotes malignant neoplasm of the major salivary glands.
Adenoid cystic carcinoma is known for its slow-growing nature but has a high potential for local invasion and distant metastasis. It is characterized by its ability to infiltrate nerves, resulting in pain and other neurological symptoms. ACC is typically diagnosed through a combination of imaging techniques, biopsy, and histopathological examination of the tumor tissue.
Treatment options for ACC often involve a multidisciplinary approach, including surgery, radiation therapy, and sometimes chemotherapy. The prognosis for ACC can vary depending on the site of origin and the extent of the disease. However, due to its aggressive behavior and tendency to recur, long-term follow-up and surveillance are crucial for patients diagnosed with adenoid cystic carcinoma.